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Coronary vasommion is abnormal in hypertensive patients. a s
evidenced by reduced coronary vasodilator reserve, but endothe-
Hum-dependent coronary vasamalion in hypertensive patients has
not been studied. To assess the integrity of endotheliumdepetdent
vamdflatinn, the response of coronary arteries to acetylcholine (an
endothelium-dependent vasodilator) and nitroglycerin (an
endo-
thelium-independent
vasodilator) was studied in 14 patients un-
dergoing cardiac calheterization. Eight patients with essential
hypertension were compared with six normotensive patients . None
had obstructive disease detectable by coronary arteriography .
Coronary artery diameter was measured with digital-subtracted
arteriography and coronary blood flow velocity with a Doppler
flow velocity catheter .
At baseline, coronary artery diameter was similar in the
hypertensive and the normotensive control patients (2.4 t 0 .3 vs.
2 .8 ± 0
.7 mm) . During intracoronary acetylcholine infusion
(30 pg/min), coronary artery diameter decreased to 1 .3 m 0.7 mm
Angina pectoris is frequently reported by hypertensive pa-
tients. Although angina is often due to atherosclerotic epi-
cardial vessel narrowing, it can also occur in hypertensive
patients in the absence of epicardial coronary artery disease
(1-4). Previonv studios (1,214) have shown that hypertensive
patients with angina can have a reduction in maximal coro-
nary vasodilation in response to pharmacologic vasodilation
or pacing-induced stress . A recent study (4) indicated that
myocardial ischemia and reduced coronary vasodilation con
occur in hypertensive patients who have neither aihcaoock-
rotic coronary disease nor left ventricular hypertrophy.
Therefore, extrinsic compression of the coronary microvas-
culature by hypertrophied myocardium does not appear to
he the only mechanism of reduced coronary vasodilation in
hypertensive patients . That recent study (4) suggested that
an intrinsic abnormality of the coronary vasculature may
limit coronary vasodilation in these patients .
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in the hypertensive patients (p < 0 .005), but was unchanged 12.7
± 0 .0 mm) in the normotensive paikuts. With ;Mr oronarv
nitroglycerin (2110 pg), coronary artery diameter increased signi6
icantiy in both groups . Calculated coronary blood tow decreased
during Acetylcholine inrnsiea by 59 ± 31% in the hypertensive
patients but increased by 3 s 3% in the normmensi,. group (p <
0 .005). There was a significant negative enrrntatian between the
percent change in estimated coronary blood flow during acetyl-
choline infusion and mean arterial pressure measured at hacelrle
(r = 0.67, p < 0.02)
.
Therefore, these hypertensive patients exhibited marked cor-
onary vasoeonstricdas in response to intracoronary aretylhaloe
but normal vasodilation in response to nitroglycerin, suggesting
abnormal endothegum-dependent vuedilatau . The otter my be
a mechanism contributing to reduced coronary vasodilator re-
serve and angina perturis in hypertensive patients .
(J Am Call Cardof 1992 ;19 :809-13)
One potential mechanism to explain reduced coronary
vasodilation in hypertensive patients is an abnormality of
endothelium-dependent vasodilation . In 1980, Furchgott and
7awadzki (5) first observed that the endothelium
modulates
arterial lone by releasing an endothelium-derived relaxing
factor- Many studies (6-8)
have now demonstrated that the
endothelium releases several relaxing and constricting fac-
tors in response to a variety of stimuli and that cndothelid-
dependent vasomotion can be impaired in many discuses
including hypertension .
Studies in hypertensive anima models (9-13) have shown
that endothelium-dependent vasodilation
is
impaired in both
large and small arteries
. Several studies (10,14) have dem-
onstrated the presence of endothelium-derived constricting
factors in spontaneously hypertensive rats. In addition, it
has been shown (15) that decreased endothelium-dependent
vasodilation can be partially reversed in rats with sat-
induced hypertension when the hypertension is normalized .
These previous animal studies (9-15) have provided strong
evidence that endothelium-dependent vasomotion is abnor-
mal in hypertensive animals .
Human studies (16-19) have demonstrated abnormal cor-
onary artery endothelial function in patients with atheroscle-
rosis and several other diseases. In one previous study, the
investigators (16) demonstrated paradoxic coronary vaso-
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constriction in response to acetylcholine (which is normally
an endothelium-dependent vasodilator) in patients with ath-
erosclerotic coronary artery disease . The same group 120)
also reported that risk Factors for atherosclerotic coronary
artery disease are associated with abnormal coronary vaso-
motion in patients with early atherosclerotic disease
. How-
ever, in these patients with early atherosclerosis hyperten-
sion did not appear to be an independent predictor of
coronary vasoconstriction.
Endothelium-dependent coronary vasodilntion has rot
been studied previously in hypertensive patients . although
two studies (21 .22) have examined endoithelium-ilcipcn d ent
vasomotion in the peripheral vaseulmure of such patients- In
both studies (21,22), forearm blood flow increased to a lesser
degree in response to acetylcholine in hypertensive patients
than in normolensive control subjects, indicating endothelial
impairment of the peripheral vasculature in hypertensive
patients.
On the basis or studies of endothelium-dcpcadtnt vase-
motion in animal models of hypertension and the previous
clinical studies, we hypothesized that there is an abnormality
of endothelium-dependent coronary vasomotion in hyper-
tensive patients . To study this hypothesis . we examined the
coronary vasomotor response to the endothelium-dependent
vasodilator acetylcholine and the endothelium-independent
vasodilator nitroglycerin in patients undergoing diagnostic
cardiac catheterizalion for the evaluation of chest pain .
Methods
Patient selection. Fourteen patients with a history of
angina like chest pain undergoing diagnostic cardiac cathe-
lerization were studied . Eight patients, two women and six
men, with a mean age of 32 - 9 years, had a history of
essential hypertension requiring long-term therapy . Six pa-
tients, five women and one man with a mean age of 52 ± 14
years . had no history of hypertension and were notmotcn-
sive during the hospital stay . Cardioactive medications were
withheld in all patients for >24 h before catheterization- The
cnlheterization protocol was approved by the Institutional
Review Board of University Hospital and all patients gave
informed consent before undergoing the procedure .
In nil patients, normal coronary artery anatomy was
documented by coronary arteriugraphy and normal left
ventricular function by contrast ventrieulography . A period
of 15 min was allowed between the injection of contrast
medium and initiation ul'the experimental protocol .
Catheter placement. A bipolar pacing Catheter was intro-
duced and advanced to the pulmonary artery to be used for
right ventricular pacing if necessary doting the study proto-
col. A standard 8F coronary angioplasty guiding catheter
was placed at the let coronary artery ostium
. A 3F Doppler
flow velocity catheter (23) (Millar Instruments) was intro-
duced into the left anterior descending or left circumflex
artery over a 0 .014 in. (0 .036 can) floppy guide wire . The flow
velocity catheter was advanced approximately I
to 2 cm into
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the study artery (the left anterior descending artery in 13
patients and the left circumflex artery in I patient) . The guide
wire was removed from the flow velocity catheter and the
central lumen was nsed for suhselcetive drug infusion into
the coronary sanery .7he Doppler range control was adjusted
to give maximal peak blood flow velocity at baseline and the
range control was not changed thereafter. Constant catheter
position was maintained by repeatedly checking the position
with fluoroscopy
. During flow velocity measurements, the
guiding catheter was retracted . slightly from the left coronary
cation to allow unimpeded blood flow into the left coronary
artery, Phasic Doppler flow velocity was recorded and peak
diastolic flow velocity data are reported . The guiding cathe-
ter was used to monitor systemic arterial blood pressure and
mean arterial pressure was determined electronically .
Study protocol . At hoseline, mean arterial pressure and
coronary flow velocity were recorded . Coronary arteriogra-
phy was performed with use of both cinearteriography and
digital subtraction arteriography . Acetylcholine chloride
(Sigma Chemieatsl was infused subselectively into the
study artery through the flow velocity catheter at a rate of
15 yvgimin 10 .5 mUmin) . If a left anterior descending or
circumflex artery blood flow of 80 mlimin is assumed, this
infusion rate resulted in an intracoronary concentration of
approximately 10 - "M . Acetylcholine was infused for 3 min
and repeal recordings of mean arterial pressure and coronary
flow velocity were obtained . Coronary arteriography was
repeated .
When hemodynamic variables returned to baseline val-
ues, acetylcholine infusion was restarted at 30 µg1min
1I mllmin) . The infusion was continued for 3 min and mean
arterial pressure and coronary flow velocity were again
recorded and coronary aneriography was repeated .
New, rtitroghreriu (200 pp) (Dupont Critical Care) was
administered as a single bolus injection through the left
coronary artery guiding catheter (24)
.
Nitroglycerin was
administered into the left main coronary artery rather than
subselectively into the study artery because of ease of rapid
administration and because the effect of selective and sub-
selective administraion is similar as a result of systemic
recirculation of nitroglycerin . Approximately 30 s after ni-
troglycerin administration, mean arterial pressure and coro-
nary
flow
velocity were recorded and coronary arteriogra-
phy was repeated .
Coronary arleriography. Coronary arteriography was
performed in orthogonal right anterior oblique and left
anterior oblique views that best showed the study artery
without overlap with other vessels . Camera angulation and
the height of the image intensifiers were maintained constant
during all subsequent arteriugrams . Coronary arteriograms
were obtained by injecting nonionic contrast medium (lopa-
midol . Squibb Diagnostics) .
Carocary arteriogrnms were recorded with use of an
ADAC Laboratories 4100 Digital Radiography System inter-
faced with a Philips X-ray unit. Exposure variables were
controlled automatically and digital images were recorded
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with use of a b-in.115-cm) image intensifier and stared in a
512 x 512 pixel matrix . Vessel diameter was measured with
an automated system that uses an edge-detection algorithm
and averages the vessel diameter along a defined length of
vessel (25) . Absolute vessel diameter was calculated by
comparing vessel diameter with the known diameter of the
arteriographic catheter . The accuracy of this system has
been validated extensively and vessel diameters measured
with this system have shown excellent correlation with the
known lumens of drilled plastic implants or with pressure-
fixed coronary arteries measured histologically ( 2_5-27). The
reproducibility of this system was validated in ow laboratory
in 20 patients undergoing successive aneriography 5 min
apart and the measured vessel diameters showed agreement
within Iv%e (r = 0.95 • SEE = 0.19) .
An end-diastolic fi-rrrrre mare chosen front the diFirrd
subtractionarreriogrrrmfar a,,e,lr'sis . A segment oft he study
artery that was relatively straight and free of side branches
and that was approximately I to 2 cm distal to the tip of the
infusion catheter was chosen for measurement of vessel
diameter . In one patient, the digital-subtracted image was
unavailable and the vessel diameter was measured from a
projected cine image with electronic calipers (Brown and
Sharpe Manufacturing).
To ensure that differences in diameter of the study artery
were not due to variability in contrast injection technique .
the coronary artery that was not receiving the drug infusion
was also measured at baseline and during each drug infusion
.
For example, in patients in whom acetylcholine was infused
into the left anterior descending coronary artery . the diam-
eter of both this artery and the left circumflex artery was
measured-the former to measure the drug effects and the
latter to ensure that there was no variability in contrast
injection technique.
Coronary lbw velocity and velocity area
index . Ta esti-
mate volumetric coronary blood flow. a velocity-area index
(VAII was calculated as follows ; VAI = coronary flow
velocity x m(D)2)', where coronary flow velocity is the peak
Doppler Bow velucity dad D is the cross-sectional coronary
artery diameter (17) .
Smtlsllkal analysts. Data are presented as mean values a
SD in the text and mean values ± SEM in the figures .
Hypertensive subjects were compared with normolensive
subjects with use of a nonpaired r test for continuous
variables
. Measurements during drug infusions were com-
pared with baseline measurements with use of paired r tests.
A p value rs0.05 defined statistical significance .
Results
I'allent characterklics
. Six of the eight hypenensive pa-
fems described their chest pain as a "rightness" or "heav-
iness" and two described it as "sherp" or "aching ." In
these patients, long-term medical therapy consisted of a
calcium channel blocking agent in seven, a beta-adrenergic
blocking agent in three, a diuretic drug in three, a long-acting
am)sH er AL .
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nitrate in five anangietensitl-convertingeesymeinhibitor in
two and aspirin in one . Two patients had a decrease in the
frequency of chest pain after starting beta-blocking therapy
for hypertension and one patient had relief or chest pain with
a nitrate. Face patients had previous hospital admissions for
suspected myocardial infarction and one of these had a
previously documented non•Q wave myocardial infarction.
All right hypenensive patients underwent exercise tolerance
lesung: the test results were interpreted as equivocal in five
and as normal in three.
Four of tire sin nannmensive patients described their
chest pain as "pressure - or "heaviness" and two as
"shim" or "
;aching
." In these patients, long-term medical
therapy consisted of a calcium channel blocking agent in
four, a beta-adrenergic blocking agent in two . a long-acting
nitrate in one and aspirin in one . Two normolensive patients
had relief of chest pain with a nitrate ; four had previous
hospital admissions for suspected myocardial infarction but
none had a previous documented infarction . In three nor-
motensive patients results of exercise tolerance testing were
interpreted as equivocal and in one normolensive patient
they were interpreted as normal .
All study patients had all cardioactive medications with-
held for >24 h before cardiac cathetetdzation . Aspirin was
taken by one hypertensive patient 2 days before the study
and by one normolensive patient 3 days before the study .
The two groups were similar with respect to serum
cholesterol levels (225 ± 40
mg/dl
in the hypertensive
patients and 234 ± 57 mgldl in the normotensive patients)
and the frequency of other comorbid illness
.
Baseline hemodynanaics, The baseline mean arterial pres-
sure was 119 = 23 mm Hg in the hypertensive patients
compared with 95 ± 10 mm Hg in the normolensive patients
(p < O
.Ot). Heart rate was similar in the hypertensive and
normolensive patients (87 ± Ifi vs. 83 ± 15 beatslmio). The
two groups had a similar baseline coronary diameter (hyper-
tensive 2-4 _ 113 mat, nurmntensice 2.8
.
0.7 mm). At
baseline, coronary flow velocity was not significantly differ-
cut bctwcen groups (hypertensivc 8.1 !- 7 .4, normolensive
57 1 .9 curls), Velocity-area index was also not signifi-
cantly different between the two groups (hypertensive 32.5
27.5 vs . normolensive 37 .2 ± 20) .
Hemodynantic ad vessel diameter chaabes dud"
acetyl-
choline infusion. In the hypertensive patients, there was a
progressive decrease in vessel diameter during acetylcholine
infusions (Fig . 1).
The vessel diameter decreased from 2 .4
-
0 .3 mm at baseline to 1 .5 ± 0.8 during the 15-Irgrmin infusion
(p < 0 .05) and to 1 .3 t 0.7 during the 30-µgfmin infusion
(p < 0 .005 compared with baseline) . The decrease in vessel
diameter was visually obvious on aneriography (Fig . 2) and
in one patient, the left anterior descending artery became
totally occluded during acetylcholine infusion, requiring
immediate tremmem with intracoronary nitroglycerin . Four
of the hypertensive patients with coronary vasoconstriction
during acetylcholine infusion reported having substernal
chest pain during the infusion .
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Figure I. Coronary artery diameter in eight hypertensive patients
(Open squares) and six normotensive control patients (closed squares)
during intracoronary acetylcholine infusion of 15 pglmin (ACH •I )
and 30 Mg/min (ETCH-2) and nitroglycerin infusion of ZOO pg (NTU).
Error ban in this and subsequent figures represent staddard error of
the mean .
During the maaioral acetyfcltoline infusion, mean arterial
pressure was unchanged in the hypertensive patients (124 ±
22 mm Hg) . Heart rate also remained unchanged (88 ! 16
beats/min) . Coronary flow velocity was 8.2 ± I I cm/s (not
significantly changed from baseline). Velocity-area index
decreased from 32 .5'_ 27 .5 at baseline In 18.1 ± 26 .3 during
peak acetylcholine infusion (p < 0
.02).
Normorensive
patients. In marked contrast to the hyper-
tensive patients, the normotensive patients did not show a
significant decrease in coronary vessel diameter during ace-
tylcholine infusion (Fig . 1) . Coronary diameter in this group
was 2 .8 - 0.7 at baseline and 2 .7 a 0.7 mm during the
15-jug/min infusion (p < 0.02 vs . 1 .5 t 0 .8 mm in the
hypertensive patients) and 2 .7 ± 0.8 during the 30-vsg/min
inF
_inn (p < 0.003 vs . 1 .3 - 0.7 mm in the hypertensive
patients)
. The average decrease in coronary vessel diameter
during acetylcholine infusion in the normotensive patients
was 3 ± 5%, which was significantly less than the average
decrease of 44 ± 26% observed in the hypertensive patients
(p < 0 .005) .
During the maxitnal acetylcloline infusion, mean arterial
pressure was unchanged in the normotensive patients (87 ±
10 mot Hg) . Heart rate and coronary flow velocity were not
significantly changed during acetylcholine infusion (77 ± 17
beats/min and 6 .3 m 3 em/s, respectively)
. Velocity-area
index was 37.2 ± 20 at baseline and was not significantly
changed during acetylcholine infusion (39.7 A 29 .8) . At
baseline, velocity-area index in the normotensive patients
was not significantly different from that in the hypertensive
patients, During ma;.imal acetylcholine infusion, ve!ocity-
area index increased by 3 = 3% in the normotensive patients
compared with a 59 31% decrease in the hypertensive
patients (p < 0 .005) (Fig . 3) . Among the hypertensive and
normotensive patients, there was a negative correlation
between mean arterial pressure measured at baseline and the
JACC Val. 19, No . 4
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Figure 2
. Digital-subtracted arteriogram of the left coronary artery
in the right anterior oblique view during baseline conditions (top)
and during acetylcholine infusion 130 µg/min) (bottom), showing
marked diffuse spasm of the left anterior descending comnary artery
in response to the infusion .
percent change in velocity-area index during acetylcholine
infusion (r = 0.67, p < 0.05) (Fig. 4) .
To ensure that the observed changes in coronary artery
diameter were not due to d(fferences in contrast injection
technique, the diameter of the noninfused coronary artery
was also measured . In the hypertensive patients, the neain-
fused artery measured 2 .6 i 0 .7 mm at baseline and was
unchanged during acetylcholine infusion (2.5 - 0.6 and 2.5 -
0 .6 mm during the two infusions) . Similarly, in the nor-
motensive patients, the noninfOSed coronary artery mea-
sured 2
.7 t 0
.6 at baseline and was unchanged during
acetylcholine infusion (2 .7 m 0.6 mm and 2.7 = 0 .6 mm
during the two infusions) .
Hemodynnmic and vessel diameter changes during nitro .
glycerin injection
. In the hypertensive patients, the vessel
diameter increased normally after nitroglycerin injection,
from 2.4 s 0.3 to 2 .6'- 0 .4 mm (p < 0.05) (Fig. 1) . Coronary
flow velocity was unchanged (13 .1 ± 18 .8 cm/s), as was
velocity-area index (60 .4 x 76.1) . Mean arterial pressure and
heart rate were not significantly changed (I15 ± 27 mm Hg
and 82 ± 13 beats/min. respectively) .
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Figure 3 . Percent change from baseline (BL) in volume-area lodes
(VAll in eight hypertensive patients (open squarest and six nor-
molensive control patients (closed squares) det , r acetylcholine
infusion of 15 I glmin (ACH-l) and ?p rig/min (ACH-2) and nitro-
glycerin infusion of 200 µg INTO)
.
In the normorensive patients, the coronary vessel diam-
eter also increased after nitroglycerin injection, from 2 .8
0.7 to 3 ± 0.8 mm (p = 0
.08) (Fig. 1). This 10 i 89 increase
in coronary vessel diameter after nitroglycerin injection in
the normolensive subjects was similar to the 12 ± 9%
increase in the hypertensive patients . In the nortnotensive
group there was no significant change in coronary flow
velocity (6 .3 ± 1 .3 curls) or velocity-area index (49 .2 ± 34).
Mean arterial pressure decreased from 85 ± 11 to 80 ±
12 mm Hg (p < 0 .05). Heart rate was unchanged (87 = 0
beats/min).
Discussion
Coronary artery responses to acetylehoPme. The findings
in this study indicate that hypertensive patients have a
markedly abnormal coronary vasoconstrictor response to
intmcoronary acetylcholine compared with that of nor-
Figure 4. Relation between the percent change from baseline (BL)
in volume-area index (VAt) darting acetylcholine infusion (30
MW
min) and mean arterial pressure (MAP) at baseline in the 13 study
patients.
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motensive subjects. During acetylcholine infusion- the
hypertensive patients had a mean reduction in coronary
artery diameter of 447, compared with a reduction of only
3.W
in the n rwotcnsive patients. Because acetylcholine
normally acts as an endothelium-dependent vasodilator,
these darn indicate that the functional integrity of the coro-
nary endothelium is impaired in these hypertensive patients
.
Coronary blood flow velocity was unchanged in both the
hypertensive and the normorensive patients during acetyl-
choline infusion. However. there was a 59% decrease in the
:alcutated velocity-area index in the hypenensive patients
luring acetylcholine infusion compared with a 3% increase
In. the normolensive patients, suggesting a decrease in volu-
met tc coronary blood flow in the hypertensive p..hmots
during acetylcholine infusion
. There was a significant nega-
tive corelati"H between the change in coronary blood °now
during acetylcholine infusion and the baseline mean arterial
pressure . suggesting that the observed abnormality in endo-
thelium-dependent vasomotion was more severe in patients
with more severe hypertension . Given the marked epicardial
coronary artery vasoconstriction that was observed, it is not
possible to discern whether the apparent decrease in coro-
nary blood flow was due to increased coronary resistance at
the epicardial or the micruvascular level .
Coronary artery responses to nitroglycerin. The hypenen-
sive and normotensive patients were similar with respect to
the change in coronary artery diameter after nitroglycerin
injection: both groups showed vasodilation, Because nitro-
glycerin is an endothelium-independent vasodilator- these
data indicate that the coronary arteries of the hypertensive
patients are capable of dilating to a degree similar to that
observed in the arteries of normorensive patients . The
normal response to nitroglycerin in the hypertensive patients
indicates that the defect in coronary vasodilation in response
to acetylcholine in these patients is not due to hyporespon-
siveness of the vascular smooth muscle to endothelium-
derived relaxing factor because this factor has been shown to
be a nitrovasodilator and would he expected to have the
same effect as nitroglycerin
(28).
The degree of coronary
artery vnsodilation that was seen in response to nitroglycerin
in the hypertensive and normorensive patients is similar to
that previously reported (24) .
The differences between the hypertensive and normoten-
sive subjects were not due to differences in age or serum
cholesterol because these variables were similar in the two
groups . Furthermore, the reduction in coronary artery diam-
eter in the hypertensive patients during acetylcholine infu-
sion could not be
due to differences in contrast injection
technique . Simultaneous contrast injection into the coronary
artery branch not receiving acetylcholine (the circumflex
artery in most patients) showed that the artery not receiving
acetylcholine was unchanged in diameter from baseline in
both groups, indicating consistent contrast injection
throughout the study.
Comparison with previous Indies. The lack of coronary
vasodilation with acetylcholine observed in the normoten-
8 1 4
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Sire patients in this study is in contrast to results of a
previous study (16) that described vasodilation, but is in
agreement with data from three previous studies (17-191 that
reported a lack of vasodilation with acetylcholine in patients
with arteriographically normal coronary arteries . The ditfer-
unce between our study and the previous study by Ludmer
el al
. (16) may be related to differences in study protocols . In
our study, we infused acetylcholine subselectively into the
coronary artery through an infusion catheter to eliminate
spillage from the study artery, resulting in higher doses of
acetylcholine in that artery . A previous study (29) showed
that acetylcholine in higher doses causes mild vasoconstric-
tion of nrcriographically normal coronary arteries, as was
seen in our control patients and in those of previous studies
(17-19), Nevertheless, at the concentrations ol'acetylcholine
used in this study, there was o ma-ked difference m the
coronary vasomotor response to acetylcholine between the
hypertensive and normotensive patients .
A previous study (30) demonstrated that endothelium-
dependent coronary vasodilation is impaired in patients with
evidence of early atherosclerosis . That study (30) classified
patients according to whether there were intraluminal irreg-
ularities on coronary arteriography suggestive of early ath-
erosclerosis and found that patients with such a finding had
vasoconstriction in response to acetylcholine
. The hyperten-
sive patients in our study had no intraluminal irregularities or
other arteriographic evidence of early atherosclerosis, mak-
ing early atherosclerosis an unlikely explanation for the
observed abnormal coronary vasomotion. It is known that
coronary arteriography underestimates the degree of ather-
osclernsis (31 ) . Because hypertension is a known risk factor
['or the development of atherosclerosis, it is possible that
atteriographically undetectable atherosclerosis accounts for
the observed abnormality in endothelium-dependent vaso-
motion. However, patients with more severe hypertension at
baseline study had more severe vasocomtrietion, as evi-
denced by the negative correlation between the baseline
blood pressure and the change in velocity-area index during
acetylcholine infusion . This finding suggests that the abnor-
mal vasoconstrictive response to acetylcholine was due to
the hypertension and not to early undetectable atheroscle-
rosis . Nevertheless, it is not possible to discern whether the
abnormal vasoconstriction was due to acute hypertension or
to vascular changes associated with chronic hypertension .
Potential mechanisms . Acetylcholine-induced vasocon-
striction in the hypertensive patients may be due to a relative
decrease in release of endothelium-derived relaxing factor or
possibly an increase in the release of an cadothelium-
dependent vasoconstncting substance (32,33) . Luscher el al .
(33) demonstrated that acetylcholine induces vasoconstric-
tion in the spontaneously hypertensive rat
. The vasocon-
striction can be inhibited with indomethacin, an inhibitor of
eyclooxygenase, indicating that the constricting factor is a
metabolite of arachidonic acid
. It is possible that the coro-
nary constriction we observed was due to either increased
release of or increased sensitivity to an endothelium-derived
IACC Vol. 19. No . 4
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constricting factor . Whether acetylcholine-induced coronary
vasoconstriction in hypertensive patients can be reversed by
inhibiting arachidonic acid metabolism with drugs such as
indomethacin is a question requiring further study .
Only four of the eight hypertensive patients and none of
the six normotensive patients experienced reproducible an-
gina during acetylcholine infusion . Most likely, coronary
constriction induced by acetylcholine in this protocol was
not prolonged enough to uniformly cause myucardialisch-
emia under these conditions
. It was not our purpose to
reproduce clinical symptoms in these patients, but rather to
study coronary physiology in hypertensive patients . How-
ever, it is interesting to speculate how this abnormality of
endothelial-dependent vasonmtion might contribute to an-
gina in such patients . It is known that endothelium-derived
relaxing tactor has a role to coordinating relative myocardial
perfusion (34) and may cause a preferential increase in sub-
endocardial perfusion (35). An abnormality in endothelium-
dependent vasodilation may therefore have important ad-
verse effects an microvascular blood flow in hypertensive
patients . Previous studies (1-4) have shown that hyperten-
sive patients have decreased coronary vasodilator reserve
and it is possible that this is at least partially caused by
regional hypoperfusion that results from impaired endothe-
lium-dependent vasodilating mechanisms .
Conclusions
. Hypertensive patients have markedly ab-
normal coronary vasoconstriction in response to intracoro-
nary infusion of acetylcholine, an endothelium-dependent
vasodilator
. but have a normal response to intracoronary
nitroglycerin, an endothelium-independent vasodilator
.
These findings suggest that cndothclium-dependent coronary
vasodilation is abnormal in these hypertensive patients and
have important implications concerning the pathophysiotogy
of the cardiac manifestations of hypertension .
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